Patent classifications
A61B2018/00261
Methods and Apparatus for Monopolar Renal Neuromodulation
Methods and apparatus are provided for monopolar neuromodulation, e.g., via a pulsed electric field. Such monopolar neuromodulation may effectuate irreversible electroporation or electrofusion, necrosis and/or inducement of apoptosis, alteration of gene expression, action potential attenuation or blockade, changes in cytokine up-regulation and other conditions in target neural fibers. In some embodiments, monopolar neuromodulation is applied to neural fibers that contribute to renal function. In some embodiments, such monopolar neuromodulation is performed bilaterally.
CRYOGENIC CATHETERS
A medical device includes an elongate shaft having a proximal end portion, a distal end portion, and a defining a lumen therebetween. The distal end portion defines al least one slot. An expandable member is disposed, within the lumen, the expandable member being configured to protrude outward from the at least one slot when expanded with cryogenic fluid.
SYSTEMS, DEVICES, AND METHODS FOR FOCAL ABLATION
Systems, devices, and methods for electroporation ablation therapy are disclosed, with the device including a set of splines coupled to a catheter for medical ablation therapy. Each spline of the set of splines may include a set of electrodes formed on that spline. The set of splines may be configured for translation to transition between a first configuration and a second configuration.
Neuromodulation cryotherapeutic devices and associated systems and methods
- Naomi Buckley ,
- Benjamin J. Clark ,
- Michael Cummins ,
- Danny Donovan ,
- Mark Gelfand ,
- Luke Hughes ,
- Brian Kelly ,
- Gary Kelly ,
- Grace Kelly ,
- John Kelly ,
- Mark S. Leung ,
- Gwenda Francis ,
- Barry Mullins ,
- Karun D. Naga ,
- Stephen Nash ,
- Eric RYBA ,
- Fiachra Sweeney ,
- Vincenzo Tilotta ,
- Roman Turovskiy ,
- Lana Woolley ,
- Denise ZARINS ,
- Michael Turovskiy
Neuromodulation cryotherapeutic devices and associated systems and methods are disclosed herein. A cryotherapeutic device configured in accordance with a particular embodiment of the present technology can include an elongated shaft having distal portion and a supply lumen along at least a portion of the shaft. The shaft can be configured to locate the distal portion intravascularly at a treatment site proximate a renal artery or renal ostium. The supply lumen can be configured to receive a liquid refrigerant. The cryotherapeutic device can further include a cooling assembly at the distal portion of the shaft. The cooling assembly can include an applicator in fluid communication with the supply lumen and configured to deliver cryotherapeutic cooling to nerves proximate the target site when the cooling assembly is in a deployed state.
APPARATUSES AND METHODS FOR HIGH DENSITY SENSING AND ABLATION DURING A MEDICAL PROCEDURE
A medical device comprising a first shaping element, a second shaping element located distally with respect to the first shaping element, a support structure that extends between the first and the second shaping elements, where each of the first and the second shaping elements are transversely oriented with respect to a longitudinal axis that extends through a center of each shaping element, and a plurality of interactive elements. An apparatus for an elongate medical device comprising a flexible planar substrate, a support structure, and a plurality of interactive elements. A helical medical device comprising a first planar substrate, wherein the first planar substrate has a helical shape and a second planar substrate coupled with the first planar substrate, wherein the second planar substrate includes a plurality of interactive elements.
APPARATUS AND METHOD FOR DELIVERING PULSED ELECTRIC FIELD THERAPY
Methods and apparatuses are disclosed for providing pulsed electrical treatment (including high voltage, sub-microsecond pulsed electric energy) to a body lumen. The methods and apparatuses of the present disclosure enhance ablation of the treatment area and/or reduce or eliminate arcing between the electrodes with a use of the filling materials.
ABLATION DELIVERY USING A CATHETER HAVING A SEMI-PERMEABLE INFLATABLE BALLOON STRUCTURE
Embodiments of the present disclosure relate to treating diseased tissue with ablation therapy. In an embodiment, an apparatus comprises a catheter having an elongate body extending between a proximal end and a distal end. The apparatus further includes a balloon structure arranged proximal to the distal end of the catheter, wherein the balloon structure has a first portion with a first permeability and a second portion with a second permeability such that the first permeability is different than the second permeability. In addition, the apparatus includes a first electrode arranged on or within the balloon structure and configured to: transmit current through the first portion, receive current transmitted through the first portion or both.
Systems, devices, and methods for focal ablation
Systems, devices, and methods for electroporation ablation therapy are disclosed, with the device including a set of splines coupled to a catheter for medical ablation therapy. Each spline of the set of splines may include a set of electrodes formed on that spline. The set of splines may be configured for translation to transition between a first configuration and a second configuration.
METHODS AND SYSTEMS FOR PREVENTING BLEEDING FROM THE LEFT ATRIAL APPENDAGE
The disclosure presents methods and systems for applying a suction force to a surface of a left atrial appendage (LAA) with a tube attached to an exterior surface of an inflatable balloon. The disclosure also presents methods and systems for inflating a first inflatable balloon within a cavity of a left atrial appendage (LAA). A method may include applying a suction force with at least one tube coupled to the first inflatable balloon to attract the first inflatable balloon to an interior surface of the LAA or to a second inflatable balloon. A method may include puncturing, using a tissue-penetrating tip, a target surface of the LAA.
Renal neuromodulation for treatment of human patients
Methods and apparatus are provided for monopolar neuromodulation, e.g., via a pulsed electric field. Such monopolar neuromodulation may effectuate irreversible electroporation or electrofusion, necrosis and/or inducement of apoptosis, alteration of gene expression, action potential attenuation or blockade, changes in cytokine up-regulation and other conditions in target neural fibers. In some embodiments, monopolar neuromodulation is applied to neural fibers that contribute to renal function. In some embodiments, such monopolar neuromodulation is performed bilaterally.